Alert: We're here for you. Learn how COVID-19 may affect your mesothelioma treatment and doctor appointments.

Dr. Edward Levine

Dr. Edward Levine

Surgical Oncologist

Dr. Edward A. Levine is the chief of surgical oncology services at Wake Forest Baptist Medical Center and a nationally recognized specialist in the use of HIPEC in combination with cytoreductive surgery for peritoneal surface malignancies.

Get in touch
Jump to a Topic:

About Edward Levine

Accolades
  • Peritoneal Mesothelioma icon

    Peritoneal Mesothelioma

  • Research Excellence icon

    Excellence in Research

  • Team Leader icon

    Team Leader

  • Heated Chemotherapy icon

    Hyperthermic Intraperitoneal Chemotherapy

Get to Know Dr. Edward A. Levine

Dr. Edward Levine is chief of surgical oncology services at the Wake Forest Baptist Medical Center Comprehensive Cancer Center in Winston-Salem, North Carolina.

He is recognized as a specialist in treating peritoneal surface malignancies, including peritoneal mesothelioma, a rare and aggressive cancer caused by asbestos exposure.

Levine is internationally recognized for the treatment combination of cytoreductive surgery and hyperthermic intraperitoneal chemotherapy, often known as HIPEC, which has dramatically improved patient outcomes in recent years.

Clinical interests include stomach, breast, liver and esophageal cancers, along with melanoma and other gastrointestinal malignancies.

Levine also serves as a professor of surgical oncology, joining Wake Forest Baptist Medical Center in 1998, where he has been principal investigator in dozens of clinical trials designed to improve treatment protocols.

Specialties of Dr. Edward A. Levine

  • Mesothelioma

  • HIPEC

  • Gastrointestinal cancers

  • Appendiceal cancer

  • Melanoma

  • Research

  • Esophageal cancer

  • Sentinel lymph node mapping

Dr. Edward A. Levine’s Experience and Medical Education

  • Wake Forest Baptist Medical Center

  • Rosalind Franklin University of Medicine and Science

  • University of Illinois Hospital (Fellowship)

  • Michael Reese Hospital and Medical Center (Residency)

  • Finch University of Health Sciences, Chicago Medical School (M.D.)

Awards and Certifications

  • America’s Top Doctors for Cancer, Castle Connolly

  • American Board of Surgery

  • American Association of Clinical Oncology

  • Association for Academic Surgery

  • National Surgical Adjuvant Breast and Bowel Project

Mesothelioma Clinical Trials Under Edward A. Levine, M.D.

  • A phase I clinical trial studying the safety and potential efficacy of talimogene laherparepvec, an immunotherapy agent aimed at various peritoneal surface malignancies, including peritoneal mesothelioma.

Doctor talking to patients

Get the Best Treatment

Get help connecting with Dr. Levine and find the treatment that's best for you.

Get Help Today

Helping to Advance Mesothelioma Treatment

Levine has helped pioneer a dramatic improvement in treating peritoneal mesothelioma cancer over the past two decades, through research and specialization in the HIPEC/cytoreductive surgery combination.

“This is a fascinating disease. And the truth is, we’re able to help most of these patients now,” he said. “We know a lot more about this disease than we did 10 year ago when it was absolutely uniform and we didn’t understand the subtypes of it.”

Too often, Levine hears people talk about the gloom and doom of this once untreatable disease, and of patients giving up before finding a specialty center with the latest expertise in treating it.

“The molecular underpinnings of this disease are only now being sorted out in detail,” he said. “To have a patient read something that is totally wrong, then get completely discouraged, just go home and die — when maybe there was treatment available — is frustrating. It shouldn’t be that way.”

See More Top Mesothelioma Doctors

Publications of Dr. Edward A. Levine

  • Binkley, P.F. & Levine, E. (2019, September). Organizational Strategies to Create a Burnout-Resistant Environment. Clinical Obstetrics Gynecology.

  • Enomoto, L.M. et al. (2019, July 31). Outcomes After Adjuvant Hyperthermic Intraperitoneal Chemotherapy for High-Risk Primary Appendiceal Neoplasms After Complete Resection. Annals of Surgical Oncology

  • Levine, E. (2019, March 27). Extensive Intraoperative Peritoneal Lavage to Prevent Metastases From Gastric Cancer: The Elegance of Simplicity. JAMA Surgery.

Disclaimer: Dr. Edward Levine has no professional affiliation with Asbestos.com.

stethoscope icon
Get Help Contacting this Doctor

We value your privacy. By submitting, you agree to our privacy policy and disclaimer.

Asbestos.com Mesothelioma Packet

Get a Free Treatment Guide Sent Overnight

Get Yours Now

Find Ways to Pay for Treatment Costs

Get Started

Find an Active Mesothelioma Clinical Trial

Find Now

Senior Content Writer

Tim Povtak is an award-winning writer with more than 30 years of reporting national and international news. His specialty is interviewing top mesothelioma specialists and researchers, reporting the latest news at mesothelioma cancer centers and talking with survivors and caregivers.

Walter Pacheco, Managing Editor at Asbestos.com
Edited by

1 Cited Article Sources

The sources on all content featured in The Mesothelioma Center at Asbestos.com include medical and scientific studies, peer-reviewed studies and other research documents from reputable organizations.

  1. Wake Forest Baptist Health. (n.d.). Edward A. Levine, MD. : Retrieved from: https://www.wakehealth.edu/Providers/L/Edward-A-Levine#nav-topics
  •  
  •  
  •  

Did this article help you?

Did this article help you?

Thank you for your feedback. Would you like to speak with a Patient Advocate?

Share this article

Last Modified October 12, 2020

Get Your Free Mesothelioma Guide Chat live with a patient advocate now